Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients

The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors ha...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 10; no. 7; p. e0133589
Main Authors Takahashi, Yuta, Nagata, Naoyoshi, Shimbo, Takuro, Nishijima, Takeshi, Watanabe, Koji, Aoki, Tomonori, Sekine, Katsunori, Okubo, Hidetaka, Watanabe, Kazuhiro, Sakurai, Toshiyuki, Yokoi, Chizu, Kobayakawa, Masao, Yazaki, Hirohisa, Teruya, Katsuji, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Mine, Sohtaro, Igari, Toru, Takahashi, Yuko, Mimori, Akio, Oka, Shinichi, Akiyama, Junichi, Uemura, Naomi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 24.07.2015
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
AbstractList The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/[mu]L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/[mu]L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today’s rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.BACKGROUNDThe prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.METHODSTrends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).RESULTSCE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.CONCLUSIONSThis large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today’s rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.
Audience Academic
Author Mimori, Akio
Sekine, Katsunori
Kobayakawa, Masao
Mine, Sohtaro
Uemura, Naomi
Kikuchi, Yoshimi
Watanabe, Koji
Yokoi, Chizu
Igari, Toru
Shimbo, Takuro
Yazaki, Hirohisa
Akiyama, Junichi
Takahashi, Yuko
Okubo, Hidetaka
Gatanaga, Hiroyuki
Nishijima, Takeshi
Aoki, Tomonori
Takahashi, Yuta
Oka, Shinichi
Nagata, Naoyoshi
Sakurai, Toshiyuki
Watanabe, Kazuhiro
Teruya, Katsuji
AuthorAffiliation 6 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan
University of Wisconsin Medical School, UNITED STATES
2 Ohta Nishinouchi Hospital, Fukushima, Japan
5 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
3 Division of AIDS Clinical Center (ACC), National Center for Global Health and Medicine, Tokyo, Japan
4 Department of Pathology, National Center for Global Health and Medicine, Tokyo, Japan
1 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan
AuthorAffiliation_xml – name: University of Wisconsin Medical School, UNITED STATES
– name: 6 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan
– name: 5 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
– name: 4 Department of Pathology, National Center for Global Health and Medicine, Tokyo, Japan
– name: 3 Division of AIDS Clinical Center (ACC), National Center for Global Health and Medicine, Tokyo, Japan
– name: 1 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan
– name: 2 Ohta Nishinouchi Hospital, Fukushima, Japan
Author_xml – sequence: 1
  givenname: Yuta
  surname: Takahashi
  fullname: Takahashi, Yuta
– sequence: 2
  givenname: Naoyoshi
  surname: Nagata
  fullname: Nagata, Naoyoshi
– sequence: 3
  givenname: Takuro
  surname: Shimbo
  fullname: Shimbo, Takuro
– sequence: 4
  givenname: Takeshi
  surname: Nishijima
  fullname: Nishijima, Takeshi
– sequence: 5
  givenname: Koji
  surname: Watanabe
  fullname: Watanabe, Koji
– sequence: 6
  givenname: Tomonori
  surname: Aoki
  fullname: Aoki, Tomonori
– sequence: 7
  givenname: Katsunori
  surname: Sekine
  fullname: Sekine, Katsunori
– sequence: 8
  givenname: Hidetaka
  surname: Okubo
  fullname: Okubo, Hidetaka
– sequence: 9
  givenname: Kazuhiro
  surname: Watanabe
  fullname: Watanabe, Kazuhiro
– sequence: 10
  givenname: Toshiyuki
  surname: Sakurai
  fullname: Sakurai, Toshiyuki
– sequence: 11
  givenname: Chizu
  surname: Yokoi
  fullname: Yokoi, Chizu
– sequence: 12
  givenname: Masao
  surname: Kobayakawa
  fullname: Kobayakawa, Masao
– sequence: 13
  givenname: Hirohisa
  surname: Yazaki
  fullname: Yazaki, Hirohisa
– sequence: 14
  givenname: Katsuji
  surname: Teruya
  fullname: Teruya, Katsuji
– sequence: 15
  givenname: Hiroyuki
  surname: Gatanaga
  fullname: Gatanaga, Hiroyuki
– sequence: 16
  givenname: Yoshimi
  surname: Kikuchi
  fullname: Kikuchi, Yoshimi
– sequence: 17
  givenname: Sohtaro
  surname: Mine
  fullname: Mine, Sohtaro
– sequence: 18
  givenname: Toru
  surname: Igari
  fullname: Igari, Toru
– sequence: 19
  givenname: Yuko
  surname: Takahashi
  fullname: Takahashi, Yuko
– sequence: 20
  givenname: Akio
  surname: Mimori
  fullname: Mimori, Akio
– sequence: 21
  givenname: Shinichi
  surname: Oka
  fullname: Oka, Shinichi
– sequence: 22
  givenname: Junichi
  surname: Akiyama
  fullname: Akiyama, Junichi
– sequence: 23
  givenname: Naomi
  surname: Uemura
  fullname: Uemura, Naomi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26208220$$D View this record in MEDLINE/PubMed
BookMark eNqNk11rFDEUhgep2A_9B6IBQRTcNR-zs0kvhFJau7DQ0tbehmxysps6m6xJptr_4w81u91KtxSRuchw5nnf5LyTs1tt-eChql4T3CdsSD5fhy561fYXpdzHhLEBF8-qHSIY7TUUs60H79vVbkrXGA8Yb5oX1TYtRU4p3ql-j4Of9i4hztFlBG8Sch4dpbCYqSmoFh0qb5xxKrmEziLcqBa8BlSq6CCloJ3KYNC5S9_RsdI5xIR-ujxDIa7W0GV0MrpCI29BZxf8PhpD0fmEbAzz4oOOvAlJh4XT6CJ35hYFizj-RIlAZyo78Dm9rJ5b1SZ4tV73qm_HR5eHJ73x6dfR4cG4pxtBc6_mQ2UshXqCKRbaKKUxt9hw0TClieaUaKuMZpSzARHNBGAiWANCUwVDy9le9fbOd9GGJNcBJ0kawRtCasEKMbojTFDXchHdXMVbGZSTq0KIU6lidroFWbIvCVuGB1jXxtYCWFNzRcUQOFXCFq8v6926yRyMLp1G1W6Ybn7xbian4UbWA1JzgovBh7VBDD86SFnOXdLQtspD6FbnFuXQhNUFffcIfbq7NTUtv1k6b0PZVy9N5UFNqRCCk2Gh-k9Q5TEwd7rcRutKfUPwcUNQmAy_8lR1KcnRxfn_s6dXm-z7B-ysXNc8S6HtlvcsbYJvHib9N-L7MSjA_h2gY0gpgpXaZbX0Ka25VhIslzN3H5pczpxcz1wR14_E9_7_lP0BOS8wuw
CitedBy_id crossref_primary_10_1016_j_med_2024_01_002
crossref_primary_10_1155_2019_3585136
crossref_primary_10_1002_jcla_23826
crossref_primary_10_1177_2050640616684404
crossref_primary_10_1556_650_2023_32768
crossref_primary_10_12998_wjcc_v10_i30_10896
crossref_primary_10_1093_dote_doy094
crossref_primary_10_1097_MPG_0000000000003927
crossref_primary_10_1016_j_med_2024_01_009
crossref_primary_10_36106_gjra_6409753
crossref_primary_10_1007_s11938_023_00435_z
crossref_primary_10_25208_0042_4609_2017_93_3_21_31
crossref_primary_10_3389_fmicb_2022_983348
crossref_primary_10_1111_myc_13585
crossref_primary_10_1097_MPG_0000000000003523
crossref_primary_10_22416_1382_4376_2020_30_5_63_83
crossref_primary_10_1007_s40267_017_0473_z
crossref_primary_10_1136_jcp_2024_209908
crossref_primary_10_3390_ijms20236031
crossref_primary_10_1007_s00405_020_05865_4
crossref_primary_10_1016_j_jinf_2024_106172
crossref_primary_10_17941_agd_978470
crossref_primary_10_5812_archcid_114631
crossref_primary_10_1007_s40261_017_0519_y
crossref_primary_10_1155_2021_8869494
crossref_primary_10_3390_jcm8010076
crossref_primary_10_1371_journal_pone_0183951
crossref_primary_10_1055_s_0040_1714073
crossref_primary_10_1186_s13104_021_05498_8
crossref_primary_10_4253_wjge_v15_i6_480
crossref_primary_10_1111_myc_13753
crossref_primary_10_1093_ofid_ofae117
crossref_primary_10_17940_endoskopi_570941
crossref_primary_10_1007_s11695_021_05398_7
crossref_primary_10_2478_prolas_2024_0044
crossref_primary_10_1093_ajcp_aqw210
crossref_primary_10_7759_cureus_24312
crossref_primary_10_1186_s12879_023_08455_x
crossref_primary_10_1038_s41598_021_00132_w
crossref_primary_10_1111_hiv_12806
crossref_primary_10_14423_SMJ_0000000000001591
crossref_primary_10_1016_j_cgh_2018_04_035
crossref_primary_10_1155_2019_8243868
crossref_primary_10_1111_his_14063
Cites_doi 10.1093/clinids/9.1.88
10.1007/s100960050437
10.1016/0016-5085(94)90613-0
10.1056/NEJMoa001999
10.3748/wjg.v9.i10.2328
10.1007/BF02779203
10.1111/j.1442-2050.2006.00563.x
10.1592/phco.27.11.1512
10.1002/path.2104
10.1111/j.1572-0241.2000.01768.x
10.3201/eid1805.111275
10.2165/00003495-200363100-00004
10.3349/ymj.2013.54.1.160
10.1586/14787210.2.4.521
10.1016/S0016-5085(76)80347-2
10.1097/QAI.0000000000000016
10.4065/71.1.5
10.1016/S0140-6736(11)61176-8
10.1016/S0140-6736(03)14904-5
10.1046/j.1442-2050.2003.00305.x
10.1086/596757
10.1111/j.1572-0241.2005.41949.x
10.1111/j.1440-1746.2009.06188.x
10.1111/dote.12102
10.1001/archinte.1991.00400080067012
10.7326/0003-4819-78-2-271
10.1055/s-2007-1005716
10.1038/nature06516
10.1371/journal.pone.0058217
10.1128/IAI.58.1.107-113.1990
10.1006/cimm.1994.1230
10.1111/j.1468-1293.2009.00807.x
ContentType Journal Article
Copyright COPYRIGHT 2015 Public Library of Science
2015 Takahashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2015 Takahashi et al 2015 Takahashi et al
Copyright_xml – notice: COPYRIGHT 2015 Public Library of Science
– notice: 2015 Takahashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2015 Takahashi et al 2015 Takahashi et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0133589
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE






MEDLINE - Academic
Agricultural Science Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate CE Trends and Risks
EISSN 1932-6203
ExternalDocumentID 1698611493
oai_doaj_org_article_932220f3050c4df49e3648a297e82a9f
PMC4514810
3755846851
A422999817
26208220
10_1371_journal_pone_0133589
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PJZUB
PPXIY
PQGLB
RIG
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
ID FETCH-LOGICAL-c692t-487adf2e4b0209cdaac08f0d8963ac1c821cfadc32835196beeb936e9c2ae7f83
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Sep 03 00:14:33 EDT 2023
Wed Aug 27 01:32:13 EDT 2025
Thu Aug 21 14:37:16 EDT 2025
Fri Jul 11 04:57:18 EDT 2025
Fri Jul 25 11:47:13 EDT 2025
Tue Jun 17 21:10:14 EDT 2025
Tue Jun 10 20:17:45 EDT 2025
Fri Jun 27 04:53:41 EDT 2025
Fri Jun 27 04:07:19 EDT 2025
Thu May 22 20:57:10 EDT 2025
Mon Jul 21 05:59:41 EDT 2025
Thu Apr 24 22:56:36 EDT 2025
Tue Jul 01 01:53:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-487adf2e4b0209cdaac08f0d8963ac1c821cfadc32835196beeb936e9c2ae7f83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: Yuta Takahashi NN. Performed the experiments: Yuta Takahashi NN. Analyzed the data: Yuta Takahashi NN T Shimbo. Contributed reagents/materials/analysis tools: NN TN KW TA KS HO KW T Sakurai CY MK HY KT HG YK SM TI Yuko Takahashi. Wrote the paper: Yuta Takahashi NN AM SO JA NU.
Competing Interests: The authors have declared that no competing interests exist.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0133589
PMID 26208220
PQID 1698611493
PQPubID 1436336
ParticipantIDs plos_journals_1698611493
doaj_primary_oai_doaj_org_article_932220f3050c4df49e3648a297e82a9f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4514810
proquest_miscellaneous_1699493134
proquest_journals_1698611493
gale_infotracmisc_A422999817
gale_infotracacademiconefile_A422999817
gale_incontextgauss_ISR_A422999817
gale_incontextgauss_IOV_A422999817
gale_healthsolutions_A422999817
pubmed_primary_26208220
crossref_citationtrail_10_1371_journal_pone_0133589
crossref_primary_10_1371_journal_pone_0133589
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-07-24
PublicationDateYYYYMMDD 2015-07-24
PublicationDate_xml – month: 07
  year: 2015
  text: 2015-07-24
  day: 24
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2015
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References RA Giannella (ref35) 1973; 78
M Bonacini (ref25) 1991; 151
E Balish (ref33) 1990; 58
M Nkuize (ref24) 2010; 11
JH Choi (ref10) 2013; 54
PH Baehr (ref21) 1994; 106
W Lutz (ref27) 2008; 451
Y Naito (ref23) 1988; 23
N Uemura (ref15) 2001; 345
MS Lionakis (ref29) 2003; 362
KE Monkemuller (ref11) 2000; 95
J Yakoob (ref8) 2003; 9
KM Fock (ref14) 2010; 25
N Nagata (ref13) 2012; 18
A Antinori (ref4) 1995; 27
BE Kodsi (ref22) 1976; 71
Y Hamada (ref20) 2014; 65
A Chocarro Martinez (ref6) 2000; 19
A Mocroft (ref12) 2005; 100
RR Wheeler (ref1) 1987; 9
SH Yale (ref31) 1996; 71
N Tamiya (ref28) 2011; 378
JA Vazquez (ref2) 2003; 63
N Weerasuriya (ref7) 2006; 19
PG Pappas (ref3) 2009; 48
AJ Porges (ref32) 1992; 19
N Nagata (ref16) 2014
JA Underwood (ref5) 2003; 16
P Willemot (ref26) 2004; 2
N Asayama (ref18) 2014; 27
S Heidenreich (ref30) 1994; 157
CK Yeh (ref34) 1988; 1
AL Gruver (ref9) 2007; 211
S Nishimura (ref17) 2013; 8
K Asare (ref19) 2007; 27
964563 - Gastroenterology. 1976 Nov;71(5):715-9
12823199 - Dis Esophagus. 2003;16(2):66-9
18204438 - Nature. 2008 Feb 7;451(7179):716-9
3823720 - Rev Infect Dis. 1987 Jan-Feb;9(1):88-96
14562403 - World J Gastroenterol. 2003 Oct;9(10):2328-31
16722997 - Dis Esophagus. 2006;19(3):189-92
10746494 - Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):96-100
15482218 - Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32
17200946 - J Pathol. 2007 Jan;211(2):144-56
3181663 - Gastroenterol Jpn. 1988 Aug;23(4):363-70
23826847 - Dis Esophagus. 2014 Apr;27(3):214-9
1404153 - J Rheumatol. 1992 Aug;19(8):1191-4
11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9
8538233 - Mayo Clin Proc. 1996 Jan;71(1):5-13
25339607 - J Gastroenterol Hepatol. 2015 Feb;30(2):292-8
14654323 - Lancet. 2003 Nov 29;362(9398):1828-38
17963461 - Pharmacotherapy. 2007 Nov;27(11):1512-28
4567180 - Ann Intern Med. 1973 Feb;78(2):271-6
8069920 - Cell Immunol. 1994 Sep;157(2):320-7
20146733 - HIV Med. 2010 Jul 1;11(6):412-7
21885099 - Lancet. 2011 Sep 24;378(9797):1183-92
23225813 - Yonsei Med J. 2013 Jan 1;54(1):160-5
22515839 - Emerg Infect Dis. 2012 May;18(5):717-24
3216316 - J Acquir Immune Defic Syndr. 1988;1(4):361-6
2403528 - Infect Immun. 1990 Jan;58(1):107-13
1651690 - Arch Intern Med. 1991 Aug;151(8):1567-72
10685750 - Am J Gastroenterol. 2000 Feb;95(2):457-62
19191635 - Clin Infect Dis. 2009 Mar 1;48(5):503-35
24525468 - J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):312-7
20370726 - J Gastroenterol Hepatol. 2010 Mar;25(3):479-86
7980741 - Gastroenterology. 1994 Feb;106(2):509-32
15984964 - Am J Gastroenterol. 2005 Jul;100(7):1446-54
12699400 - Drugs. 2003;63(10):971-89
23555571 - PLoS One. 2013;8(3):e58217
7588351 - Endoscopy. 1995 Jun;27(5):371-6
References_xml – volume: 9
  start-page: 88
  year: 1987
  ident: ref1
  article-title: Esophagitis in the immunocompromised host: Role of esophagoscopy in diagnosis
  publication-title: Rev Infect Dis
  doi: 10.1093/clinids/9.1.88
– volume: 19
  start-page: 1191
  year: 1992
  ident: ref32
  article-title: Patients with systemic lupus erythematosus at risk for pneumocystis carinii pneumonia
  publication-title: J Rheumatol
– volume: 19
  start-page: 96
  year: 2000
  ident: ref6
  article-title: Risk factors for esophageal candidiasis
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s100960050437
– volume: 106
  start-page: 509
  year: 1994
  ident: ref21
  article-title: Esophageal infections: Risk factors, presentation, diagnosis, and treatment
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(94)90613-0
– volume: 345
  start-page: 784
  year: 2001
  ident: ref15
  article-title: Helicobacter pylori infection and the development of gastric cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa001999
– volume: 9
  start-page: 2328
  year: 2003
  ident: ref8
  article-title: Candida esophagitis: Risk factors in non-HIV population in pakistan
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v9.i10.2328
– volume: 23
  start-page: 363
  year: 1988
  ident: ref23
  article-title: Esophageal candidiasis
  publication-title: Gastroenterol Jpn
  doi: 10.1007/BF02779203
– volume: 19
  start-page: 189
  year: 2006
  ident: ref7
  article-title: A study of candida esophagitis in elderly patients attending a district general hospital in the UK
  publication-title: Dis Esophagus
  doi: 10.1111/j.1442-2050.2006.00563.x
– volume: 27
  start-page: 1512
  year: 2007
  ident: ref19
  article-title: Diagnosis and treatment of adrenal insufficiency in the critically ill patient
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.27.11.1512
– volume: 211
  start-page: 144
  year: 2007
  ident: ref9
  article-title: Immunosenescence of ageing
  publication-title: J Pathol
  doi: 10.1002/path.2104
– volume: 95
  start-page: 457
  year: 2000
  ident: ref11
  article-title: Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2000.01768.x
– volume: 18
  start-page: 717
  year: 2012
  ident: ref13
  article-title: Risk factors for intestinal invasive amebiasis in japan, 2003–2009
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1805.111275
– volume: 63
  start-page: 971
  year: 2003
  ident: ref2
  article-title: Invasive oesophageal candidiasis: Current and developing treatment options
  publication-title: Drugs
  doi: 10.2165/00003495-200363100-00004
– volume: 54
  start-page: 160
  year: 2013
  ident: ref10
  article-title: Prevalence and risk factors of esophageal candidiasis in healthy individuals: A single center experience in korea
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2013.54.1.160
– volume: 2
  start-page: 521
  year: 2004
  ident: ref26
  article-title: Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1586/14787210.2.4.521
– volume: 71
  start-page: 715
  year: 1976
  ident: ref22
  article-title: Candida esophagitis: A prospective study of 27 cases
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(76)80347-2
– volume: 65
  start-page: 312
  year: 2014
  ident: ref20
  article-title: Impact of HIV infection on colorectal tumors: A prospective colonoscopic study of asian patients
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000016
– volume: 71
  start-page: 5
  year: 1996
  ident: ref31
  article-title: Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illness and prior corticosteroid therapy
  publication-title: Mayo Clin Proc
  doi: 10.4065/71.1.5
– volume: 378
  start-page: 1183
  year: 2011
  ident: ref28
  article-title: Population ageing and wellbeing: Lessons from japan's long-term care insurance policy
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61176-8
– volume: 362
  start-page: 1828
  year: 2003
  ident: ref29
  article-title: Glucocorticoids and invasive fungal infections
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)14904-5
– volume: 16
  start-page: 66
  year: 2003
  ident: ref5
  article-title: Clinical findings and risk factors for candida esophagitis in outpatients
  publication-title: Dis Esophagus
  doi: 10.1046/j.1442-2050.2003.00305.x
– volume: 48
  start-page: 503
  year: 2009
  ident: ref3
  article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of america
  publication-title: Clin Infect Dis
  doi: 10.1086/596757
– year: 2014
  ident: ref16
  article-title: Risk of peptic ulcer bleeding associated with helicobacter pylori infection, NSAIDs, low-dose aspirin, and antihypertensive drugs: A case-control study
  publication-title: J Gastroenterol Hepatol
– volume: 100
  start-page: 1446
  year: 2005
  ident: ref12
  article-title: Decline in esophageal candidiasis and use of antimycotics in european patients with HIV
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2005.41949.x
– volume: 25
  start-page: 479
  year: 2010
  ident: ref14
  article-title: Epidemiology of helicobacter pylori infection and gastric cancer in asia
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2009.06188.x
– volume: 27
  start-page: 214
  year: 2014
  ident: ref18
  article-title: Relationship between clinical factors and severity of esophageal candidiasis according to kodsi's classification
  publication-title: Dis Esophagus
  doi: 10.1111/dote.12102
– volume: 151
  start-page: 1567
  year: 1991
  ident: ref25
  article-title: The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1991.00400080067012
– volume: 78
  start-page: 271
  year: 1973
  ident: ref35
  article-title: Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-78-2-271
– volume: 27
  start-page: 371
  year: 1995
  ident: ref4
  article-title: Presumptive clinical criteria versus endoscopy in the diagnosis of candida esophagitis at various HIV-1 disease stages
  publication-title: Endoscopy
  doi: 10.1055/s-2007-1005716
– volume: 451
  start-page: 716
  year: 2008
  ident: ref27
  article-title: The coming acceleration of global population ageing
  publication-title: Nature
  doi: 10.1038/nature06516
– volume: 8
  start-page: e58217
  year: 2013
  ident: ref17
  article-title: Factors associated with esophageal candidiasis and its endoscopic severity in the era of antiretroviral therapy
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0058217
– volume: 58
  start-page: 107
  year: 1990
  ident: ref33
  article-title: Correlates of cell-mediated immunity in candida albicans-colonized gnotobiotic mice
  publication-title: Infect Immun
  doi: 10.1128/IAI.58.1.107-113.1990
– volume: 157
  start-page: 320
  year: 1994
  ident: ref30
  article-title: Glucocorticoid-induced alterations of monocyte defense mechanisms against candida albicans
  publication-title: Cell Immunol
  doi: 10.1006/cimm.1994.1230
– volume: 11
  start-page: 412
  year: 2010
  ident: ref24
  article-title: Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy
  publication-title: HIV Med
  doi: 10.1111/j.1468-1293.2009.00807.x
– volume: 1
  start-page: 361
  year: 1988
  ident: ref34
  article-title: Oral defense mechanisms are impaired early in HIV-1 infected patients
  publication-title: J Acquir Immune Defic Syndr
– reference: 16722997 - Dis Esophagus. 2006;19(3):189-92
– reference: 15984964 - Am J Gastroenterol. 2005 Jul;100(7):1446-54
– reference: 12699400 - Drugs. 2003;63(10):971-89
– reference: 14562403 - World J Gastroenterol. 2003 Oct;9(10):2328-31
– reference: 3181663 - Gastroenterol Jpn. 1988 Aug;23(4):363-70
– reference: 8069920 - Cell Immunol. 1994 Sep;157(2):320-7
– reference: 17200946 - J Pathol. 2007 Jan;211(2):144-56
– reference: 8538233 - Mayo Clin Proc. 1996 Jan;71(1):5-13
– reference: 25339607 - J Gastroenterol Hepatol. 2015 Feb;30(2):292-8
– reference: 12823199 - Dis Esophagus. 2003;16(2):66-9
– reference: 11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9
– reference: 20370726 - J Gastroenterol Hepatol. 2010 Mar;25(3):479-86
– reference: 18204438 - Nature. 2008 Feb 7;451(7179):716-9
– reference: 23826847 - Dis Esophagus. 2014 Apr;27(3):214-9
– reference: 1404153 - J Rheumatol. 1992 Aug;19(8):1191-4
– reference: 17963461 - Pharmacotherapy. 2007 Nov;27(11):1512-28
– reference: 14654323 - Lancet. 2003 Nov 29;362(9398):1828-38
– reference: 2403528 - Infect Immun. 1990 Jan;58(1):107-13
– reference: 10685750 - Am J Gastroenterol. 2000 Feb;95(2):457-62
– reference: 19191635 - Clin Infect Dis. 2009 Mar 1;48(5):503-35
– reference: 22515839 - Emerg Infect Dis. 2012 May;18(5):717-24
– reference: 10746494 - Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):96-100
– reference: 7588351 - Endoscopy. 1995 Jun;27(5):371-6
– reference: 3216316 - J Acquir Immune Defic Syndr. 1988;1(4):361-6
– reference: 15482218 - Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32
– reference: 21885099 - Lancet. 2011 Sep 24;378(9797):1183-92
– reference: 23225813 - Yonsei Med J. 2013 Jan 1;54(1):160-5
– reference: 7980741 - Gastroenterology. 1994 Feb;106(2):509-32
– reference: 24525468 - J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):312-7
– reference: 4567180 - Ann Intern Med. 1973 Feb;78(2):271-6
– reference: 964563 - Gastroenterology. 1976 Nov;71(5):715-9
– reference: 23555571 - PLoS One. 2013;8(3):e58217
– reference: 1651690 - Arch Intern Med. 1991 Aug;151(8):1567-72
– reference: 3823720 - Rev Infect Dis. 1987 Jan-Feb;9(1):88-96
– reference: 20146733 - HIV Med. 2010 Jul 1;11(6):412-7
SSID ssj0053866
Score 2.3629549
Snippet The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's...
Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients...
Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0133589
SubjectTerms Acetaminophen
Acquired immune deficiency syndrome
Activities of daily living
Aged
Aged, 80 and over
Aging
AIDS
Alcoholic beverages
Antineoplastic drugs
Antiretroviral agents
Antiretroviral drugs
Antitumor agents
Cancer therapies
Candida
Candidiasis
Candidiasis - epidemiology
Cardiovascular diseases
Case-Control Studies
CD4 antigen
Chronic kidney failure
Cirrhosis
Coinfection
Corticoids
Corticosteroids
Defense mechanisms
Diabetes mellitus
Drug therapy
Drugs
Endoscopy
Endoscopy, Digestive System
Esophagitis
Esophagitis - epidemiology
Esophagitis - microbiology
Esophagus
Female
Gastric cancer
Gastroenterology
Glucocorticoids
Health aspects
Health risks
Hepatitis
Hepatitis B
Hepatology
Highly active antiretroviral therapy
HIV
HIV infections
HIV Infections - epidemiology
HIV tests
Hospitals
Human immunodeficiency virus
Humans
Immunosuppressive agents
Infections
Kidney transplantation
Liver
Liver cirrhosis
Liver diseases
Male
Medical diagnosis
Medical research
Medical screening
Medicine
Middle Aged
Multivariate analysis
Mycoses
Odds Ratio
Patients
Pneumonia
Population
Prednisone
Prevalence
Prevalence studies (Epidemiology)
Proton pump inhibitors
Rheumatic diseases
Risk analysis
Risk factors
Sexual behavior
Sexually transmitted diseases
Smoking
STD
Stomach cancer
Studies
Syphilis
Trends
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquhBQxCAiTSJrHXibmValddVB4qbdVb5PhRVlTJqtk98H_4oczE3miDKpUDp5XiibXxzHweJzPfEPJ6bFItc1fE3GoWc-GSuOIOHC9hPFfYHqmr8P78RRyd8U8X44uNVl-YE-bpgf3C7Uv8FJA4MMtEc-O4tEzwAmbJbZEp6RB9Yc9bH6Y8BoMXCxEK5Vie7ge97C2a2u5B0MPG2NZ9YyPq-Pp7VB4trpr2ppDz78zJja1oep_cCzEkPfD_fYvcsfUDshW8tKVvA5X0u4fk93FTX8angL7UJ7_SeU0n2LkAYASmOMSiFrCQdt5SJHNSXQkShat0rTdr6Mm8_UmnvjEPxRe3tLnufpvVkh7NzuksZHTVH-gxICcYMsWyFZiHTmrTYOXLXFNMWfxFG0eL5D0gGP3mKV3bR-RsOjk9PIpDX4ZYC5ktYzjjKOMyyyuINaU2SumkcIkpwJmVTnWRpdopoxlyuYGHV9ZWkgkrdaYs2AV7TEY1aGKb0MxVAMcVT6w0nKsU9To2lWAiVyyrTETYWkmlDqTl2Dvjquy-xOVwePFrXqJqy6DaiMT9XQtP2nGL_EfUfy-LlNvdBTDEMhhieZshRuQFWk_p61d74CgPeAZbvizSPCKvOgmk3agxr-dSrdq2nH09_weh7ycDoTdByDWwHFqFWgp4JqTzGkjuDiQBPPRgeBttfb0qbZkKWQg4I0sGd67t_-bhl_0wToq5erVtVp2MBIGU8Yg88e7Sryy2P4CQNIlIPnCkwdIPR-r5j471nENoX6TJ0_-hqx1yFwLfMb6jz_guGS2vV_YZBJfL6nmHI38AM7l3vg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxMbHAgMMQgIksiWxm8S8oDG1atEGaGxT3yLHHyViSkrTPvD_8Idyl7hhQRPwVCm-RKnv7pezffc7Ql4MdahEYlOfG8V8HtvAz7kFxwsYTyS2R2oqvI8_xpMz_mE2nLkNt9qlVW4wsQFqXSncI98PY5HGELwL9m7x3ceuUXi66lpoXCc3kLoMU7qSWbfgAl-OY1cux5Jw32lnb1GVZg9CHzbE5u6XPkcNa3-HzYPFRVVfFXj-mT956YM0vkNuu0iSHrSq3yLXTLlNbh67s_JtsuXctqavHLf067vk51FVzv1TgGPaZsPSoqQjbGUAuAJPO8QqFzCZuqgpsjvJpiaJwlW6UaTR9KSov9Fx26mH4k4urZbNb7Ve0cn0nE5dilf5lh4BlIJlU6xjgefQUakrLIUpFMUcxh-0sjQN3gCk0c8tx2t9j5yNR6eHE981avBVLKKVD4seqW1keA7Bp1BaShWkNtApeLdUoUqjUFmpFUNyN3D53JhcsNgIFUkDhsLuk0EJStkhNLI54HPOAyM05zKUWPmr85jFiWRRrj3CNvrKlGMxx2YaF1lzNJfAaqad_gy1nDkte8Tv7lq0LB7_kH-PptDJIgd3c6FazjPn0pnAQ6rAAmAGimvLhWExT_GFTRpJYT3yFA0pawtaOyTJDngEMYBIw8QjzxsJ5OEoMdFnLtd1nU0_nf-H0JeTntBLJ2QrmA4lXXEF_Cfk9-pJ7vYkAU1Ub3gHzX4zK3X22-_gzo0rXD38rBvGh2LyXmmqdSMjQCBk3CMPWs_pZhb7IUCMGngk6flUb-r7I2XxtaFB5xDrp2Hw8O-v9Yjcghh3iNvxEd8lg9VybR5DHLnKnzRg8QuKrnN-
  priority: 102
  providerName: ProQuest
Title Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/26208220
https://www.proquest.com/docview/1698611493
https://www.proquest.com/docview/1699493134
https://pubmed.ncbi.nlm.nih.gov/PMC4514810
https://doaj.org/article/932220f3050c4df49e3648a297e82a9f
http://dx.doi.org/10.1371/journal.pone.0133589
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe2TkK8TGx8LDCKQUiARKp8uEmMhNBWtbRoHdNYp75FjuOUiiopTSuxF_4a_lDuEiciqBO8uFJ8jtLz3fls3_2OkJfd2JbcTwKTKemazEssM2IJKJ7lMl9geaQiw3t87g0n7NO0O90hVc1WzcB869YO60lNVovOj-83H0Dh3xdVG3y7GtRZZqnqgEvjdgO-S_ZgbfJRVcesvlcA7fY8nUB328jGAlXg-NfWurVcZPk2V_TviMo_lqjBPbKvfUt6UgrDAdlR6SG5M9a354fkQCtyTl9rtOk398mvsyydmVdgoGkZH0vnKe1jcQOwNPC2Hua9gBDl85wi3pMospQoPKXV1KqYXs7zb3RQ1u6heLZLs1Xxm23WdDi6piMd9JW-o2dgXEHWKWa2wHtoP40zTI6ZS4pRjTc0S2hgvQUjRy9K1Nf8AZkM-le9oalLN5jS487ahG2QiBNHsQjcUS5jIaQVJFYcgL4LacvAsWUiYuki3BsYgUipiLue4tIRCkTHfUhaKUzKEaFOEoHFjpileMyYsAXmAseR53q-cJ0oNohbzVcoNa45ltdYhMVlnQ_7m5L9Ic5yqGfZIGY9alnievyD_hRFoaZFVO7iQbaahVrJQ47XVlYCJtSSLE4YV67HAvxgFTiCJwZ5hoIUlimutW0JT5gDXgEPbN8gLwoKROZIMfRnJjZ5Ho4-X_8H0ZfLBtErTZRkwA4pdLoF_CdE_GpQHjcowb7IRvcRin3FlTy0PR54sI3mLoysVGF79_O6G1-K4XypyjYFDQcC22UGeVRqTs1ZrJAAXqtlEL-hUw3WN3vS-dcCGJ2B9x_Y1uPbv_gJuQsebxcP5x12TFrr1UY9Ba9yHbXJrj_1oQ16NraDj22yd9o_v7hsF-c07cKQYPuz_xtRy33d
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkYAXxMbHCoMZBAIksiWxm8RICI3RqWXtmEY39S04jlMqpqQ0rdD-H575G7lLnLCgCXjZU6T4YiW-u5_PuS9CnnZiRwk_CSyuFbO4l9hWxBNQPJtxX2J7pCLDe3jg9Y75h3FnvEJ-VrkwGFZZYWIB1HGm8B_5tuOJwAPjXbC3s28Wdo1C72rVQqMUi3199h2ObPmb_nvg7zPX3euOdnuW6SpgKU-4CwssdBknruYRWEpCxVIqO0jsOABRlMpRgeuoRMaKYSUykM9I60gwTwvlSg1fxWDeK-QqbLw2apQ_rg94gB2eZ9LzmO9sG2nYmmWp3gJTi3Wwmfy57a_oElDvBa3ZaZZfZOj-Ga95bgPcu0VuGsuV7pSitkpWdLpGrg2Nb36NrBqYyOkLU8v65W3yY5ClE2sE8E_L6Fs6TWkXWycAjsFsu5hVAyKaT3OK1aRkkQNF4S6tBEfH9Giaf6V7ZWcgin-OaTYvrtlyQXv9E9o3IWXpazoA6AZNopg3A_PQbhpnmHozVRRjJs9oltDAfgUQSg_LmrL5HXJ8KSy8S1opMGWdUDeJYD-IuK1FzLl0JGYax5HHPF8yN4rbhFX8CpWpmo7NO07DwhXow-mpXP4QuRwaLreJVT81K6uG_IP-HYpCTYs1v4sb2XwSGggJBTrF7AQA2lY8TrjQzOMBvrAOXCmSNtlEQQrLBNoaucId7oLNIQLHb5MnBQXW_UgxsGgil3ke9j-e_AfRp6MG0XNDlGSwHEqaZA74Jqwn1qDcaFACeqnG8DqKfbUqefhbz-HJShUuHn5cD-OkGCyY6mxZ0AggcBhvk3ul5tQri_0XwCa228Rv6FRj6Zsj6fRLUXadw9kicOz7f3-tTXK9NxoOwkH_YP8BuQH2dQddAS7fIK3FfKkfgg27iB4VwEHJ58tGql8Fp7IH
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELbKIlW8IFqOLhRqEAiQSJvE3iRGQqi0XXXpQdVL-xYcxy4rqmTZ7Ar1__Ar-HXMJE5oUAW89ClSPLGSOT6P4zkIed5LPSVCEzlcK-bwwLhOwg0Ynst4KLE9UpnhvbcfbJ_wj8PecI78rHNhMKyyxsQSqNNc4T_yNS8QUQDOu2BrxoZFHGz234-_OdhBCk9a63YalYrs6IvvsH0r3g02QdYvfL-_dbyx7dgOA44KhD91wFuXqfE1T8BrEiqVUrmRcdMI1FIqT0W-p4xMFcOqZKCridaJYIEWypcavpDBvDfIzRAG0cbCYbPZAxwJApuqx0JvzWrG6jjP9Cq4XayHjeUvLYVlx4BmXeiMz_PiKqf3z9jNS4th_w65bb1Yul6p3QKZ09kimd-z5_SLZMFCRkFf2brWr--SH7t5duYcw1JAq0hcOsroFrZRAEyD2TYwwwbUtRgVFCtLyTIfisJdWiuRTunhqPhK-1WXIIp_kWk-Ka_5bEq3B6d0YMPLsrd0F2AcrIpiDg3MQ7eyNMc0nJGiGD95QXNDI_cNwCk9qOrLFvfIybWI8D7pZCCUJUJ9k8DakHBXi5Rz6UnMOk6TgAWhZH6Sdgmr5RUrW0EdG3mcx-WxYAg7qYr9MUo5tlLuEqd5alxVEPkH_QdUhYYW63-XN_LJWWzhJBZ4QOYaAGtX8dRwoVnAI3xhHflSmC5ZQUWKq2TaBsXide6D_yEiL-ySZyUF1gDJ0JrO5Kwo4sGn0_8gOjpsEb20RCYHdihpEzvgm7C2WItyuUUJSKZaw0uo9jVXivi3zcOTtSlcPfy0GcZJMXAw0_mspBFA4DHeJQ8qy2k4i70YwD92uyRs2VSL9e2RbPSlLMHOYZ8Ree7Dv7_WCpkHjIp3B_s7j8gtcLV7eCrg82XSmU5m-jG4s9PkSYkblHy-bqD6BU7rtj0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Trends+in+Esophageal+Candidiasis+Prevalence+and+Associated+Risk+Factors+with+or+without+HIV+Infection%3A+Lessons+from+an+Endoscopic+Study+of+80%2C219+Patients&rft.jtitle=PloS+one&rft.au=Takahashi%2C+Yuta&rft.au=Nagata%2C+Naoyoshi&rft.au=Shimbo%2C+Takuro&rft.au=Nishijima%2C+Takeshi&rft.date=2015-07-24&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=10&rft.issue=7&rft_id=info:doi/10.1371%2Fjournal.pone.0133589&rft.externalDocID=1698611493
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon